Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNuclear Cardiology

Effect of Myocardial Viability Assessed by Technetium-99m-Sestamibi SPECT and Fluorine-18-FDG PET on Clinical Outcome in Coronary Artery Disease

Juergen vom Dahl, Carsten Altehoefer, Florence H. Sheehan, Petra Buechin, Gernot Schulz, Ernst Ruediger Schwarz, Karl-Christian Koch, Rainer Uebis, Bruno J. Messmer, Udalrich Buell and Peter Hanrath
Journal of Nuclear Medicine May 1997, 38 (5) 742-748;
Juergen vom Dahl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carsten Altehoefer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florence H. Sheehan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petra Buechin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gernot Schulz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernst Ruediger Schwarz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl-Christian Koch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rainer Uebis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno J. Messmer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Udalrich Buell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Hanrath
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 38, Issue 5
May 1, 1997
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Myocardial Viability Assessed by Technetium-99m-Sestamibi SPECT and Fluorine-18-FDG PET on Clinical Outcome in Coronary Artery Disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Effect of Myocardial Viability Assessed by Technetium-99m-Sestamibi SPECT and Fluorine-18-FDG PET on Clinical Outcome in Coronary Artery Disease
Juergen vom Dahl, Carsten Altehoefer, Florence H. Sheehan, Petra Buechin, Gernot Schulz, Ernst Ruediger Schwarz, Karl-Christian Koch, Rainer Uebis, Bruno J. Messmer, Udalrich Buell, Peter Hanrath
Journal of Nuclear Medicine May 1997, 38 (5) 742-748;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effect of Myocardial Viability Assessed by Technetium-99m-Sestamibi SPECT and Fluorine-18-FDG PET on Clinical Outcome in Coronary Artery Disease
Juergen vom Dahl, Carsten Altehoefer, Florence H. Sheehan, Petra Buechin, Gernot Schulz, Ernst Ruediger Schwarz, Karl-Christian Koch, Rainer Uebis, Bruno J. Messmer, Udalrich Buell, Peter Hanrath
Journal of Nuclear Medicine May 1997, 38 (5) 742-748;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Revascularization in Patients With Severe Left Ventricular Dysfunction: Is the Assessment of Viability Still Viable?
  • 18F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to 18F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial
  • Increasing Benefit From Revascularization Is Associated With Increasing Amounts of Myocardial Hibernation: A Substudy of the PARR-2 Trial
  • Assessment of Myocardial Viability in Patients with Heart Failure
  • Nuclear cardiology: myocardial perfusion imaging with SPECT and PET
  • Myocardial Viability Testing and the Effect of Early Intervention in Patients With Advanced Left Ventricular Systolic Dysfunction
  • The Extent of Perfusion-F18-Fluorodeoxyglucose Positron Emission Tomography Mismatch Determines Mortality in Medically Treated Patients With Chronic Ischemic Left Ventricular Dysfunction
  • Revascularization in Severe Left Ventricular Dysfunction: The Role of Viability Testing
  • Electromechanical Properties of Perfusion/Metabolism Mismatch: Comparison of Nonfluoroscopic Electroanatomic Mapping with 18F-FDG PET
  • Radionuclide techniques for the assessment of myocardial viability and hibernation
  • Myocardial viability inchronic ischemic heart disease: Comparison of contrast-enhanced magnetic resonance imaging with 18F-fluorodeoxyglucose positron emission tomography
  • Comparison of Microsphere-Equivalent Blood Flow (15O-Water PET) and Relative Perfusion (99mTc-Tetrofosmin SPECT) in Myocardium Showing Metabolism-Perfusion Mismatch
  • Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function
  • Electromechanical mapping for determination of myocardial contractility and viability: A comparison with echocardiography, myocardial single-photon emission computed tomography, and positron emission tomography
  • Quantitative Analysis of Acute Myocardial Infarct in Rat Hearts with Ischemia-Reperfusion Using a High-Resolution Stationary SPECT System
  • Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis
  • Cardiac imaging
  • Clinical Outcome of Patients with Previous Myocardial Infarction and Left Ventricular Dysfunction Assessed with Myocardial 99mTc-MIBI SPECT and 18F-FDG PET
  • No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: A prospective, randomized comparison of patients with suspicion of jeopardized myocardium
  • Google Scholar

More in this TOC Section

  • Fasting and Nonfasting Iodine-123-Idophenylpentadecanoic Acid Myocardial SPECT Imaging in Coronary Artery Disease
  • High-Resolution Cardiac PET in Rabbits: Imaging and Quantitation of Myocardial Blood Flow
  • Comparison of Four Motion Correction Techniques in SPECT Imaging of the Heart: A Cardiac Phantom Study
Show more Nuclear Cardiology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire